Sotera Health Company
Research Sotera Health Company (SHC) on Bullrun: valuation model: 10.3% overvalued, market cap USD 5.18B, P/E 31.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSHC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Valuation signal10.3% overvalued
- Market capUSD 5.18B
- P/E31.9
- Financial periodQ2 2026
- RevenueUSD 321.38M
- Net incomeUSD 53.64M
- Free cash flowUSD 42.05M
- Gross margin55.4%
Valuation Snapshot
Bullrun's latest valuation model marks Sotera Health Company as 10.3% overvalued; latest market cap is USD 5.18B; P/E is 31.9.
Peer valuation comparison
Latest P/E is 31.92x versus a Healthcare sector median of 24.6x (29.8% above).
Latest P/E is 31.92x versus a United States median of 23.85x (33.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.16B | USD 77.95M | USD 149.18M | 55.5% | 0.27 | USD 344.62M | USD 2.14B | USD 606.04M |
| FY2024 | USD 1.10B | USD 44.40M | USD 45.09M | 54.7% | 0.16 | USD 277.24M | USD 2.22B | USD 404.91M |
| FY2023 | USD 1.05B | USD 51.38M | -USD 362.71M | 55.0% | 0.18 | USD 296.41M | USD 2.23B | USD 443.73M |
| FY2022 | USD 1.00B | -USD 233.57M | USD 95.58M | 55.5% | -0.83 | USD 395.21M | USD 1.94B | USD 350.24M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 5.18B | 31.9 | n/a | n/a |
| 2025 | 2025-12-31 | USD 5.02B | 65.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.88B | 85.5 | n/a | n/a |
| 2023 | 2023-12-29 | USD 4.76B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 2.35B | 19.4 | n/a | n/a |
| 2021 | 2021-12-31 | USD 6.66B | 57.4 | n/a | n/a |
About Sotera Health Company
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Sotera Health Company overvalued or undervalued?
Bullrun's valuation model currently marks Sotera Health Company as 10.3% overvalued.
What is Sotera Health Company's market cap?
Sotera Health Company's market capitalization is USD 5.18B.
What is Sotera Health Company's P/E ratio?
Sotera Health Company's price-to-earnings (P/E) ratio is 31.9.
What does Sotera Health Company do?
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets.